AKYNZEO
NDC 69639-106, Fosnetupitant and Palonosetron, injection, from Helsinn Therapeutics (U.S.), Inc..
- Product NDC
- 69639-106
- Status
- Listed
- Labeler
- Helsinn Therapeutics (U.S.), Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210493
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69639-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FOSNETUPITANT260 mg/20mL
- PALONOSETRON HYDROCHLORIDE.28 mg/20mL
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69639-106-01 | 69639010601 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69639-106-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8e47618e-af46-4d82-94e8-1507c042252dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69639-106
Use it
Look up 69639-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69639-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69639-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.